Aura Biosciences, Inc. cotiza a 6.27 USD y tiene una capitalización bursátil de $650M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.50 | $-0.37 |
| Estimado | $-0.37 | $-0.37 | $-0.40 | $-0.43 |
| Sorpresa | — | — | -25.0% | +14.0% |
| Métrica | AURA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -77.6% | -40.4% | -37.2% |
| ROA | -62.7% | -32.0% | -30.7% |
| Current Ratio | 8.15 | 2.84 | +5.31 |
| Debt / Equity | — | 0.28 | — |